2014
DOI: 10.1016/j.thromres.2014.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers for post thrombotic syndrome: A case-control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 33 publications
2
21
0
Order By: Relevance
“…In our cohort, circulating levels of hs-CRP were similar in the two groups of patients. This finding, which is in line with recent studies [19], may indicate a lack of sustained inflammatory response in patients with PTS. If this was the case, the role of systemic inflammation in the amplification of venous damage could be of low relevance.…”
Section: Discussionsupporting
confidence: 92%
“…In our cohort, circulating levels of hs-CRP were similar in the two groups of patients. This finding, which is in line with recent studies [19], may indicate a lack of sustained inflammatory response in patients with PTS. If this was the case, the role of systemic inflammation in the amplification of venous damage could be of low relevance.…”
Section: Discussionsupporting
confidence: 92%
“…eNOS inhibition resulted in a decrease in plasma nitrite concentration, and eNOS knockout mice had lower plasma nitrite compared to wild-type mice (Kleinbongard et al, 2003). Soluble thrombomodulin was measured as a marker of endothelial damage in which its elevated levels were associated with endothelial dysfunction and thrombosis (Ishii et al, 1991;Bouman et al, 2014;Sharma et al, 2014). ADMA is an endogenous eNOS inhibitors and its high levels are associated with vascular disorders (Böger et al, 1998;Tripepi et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…These data suggest the involvement of IL-6 in the induction and progression of VTE and its complications. There are, however, some studies that report no association between IL-6, either its blood level or genetic variants, and VTE [32][33][34].…”
Section: Risk Factors For Venous Thromboembolismmentioning
confidence: 99%